This is a multi-center, randomized, observer-blind, parallel-group, 8-weeks, non-inferiority clinical trial to compare the efficacy and safety of two brands of Simeticone for symptomatic treatment of functional dyspepsia in adults.
The aim of this study is to show non-inferiority of two brands of simeticone in adult patients suffering from functional dyspepsia.